|
Luke B. Evnin Ph.D. Director - Dr. Evnin has served on our board of directors since September 2000. Dr. Evnin is a General Partner at MPM Capital a venture capital firm focusing on global healthcare investments. Before joining MPM Capital in 1998 Dr. Evnin was affiliated with Accel Partners for seven years including four years as a General Partner. He was involved in biopharmaceutical pharmaceutical medical device and healthcare service companies for Accel Partners' funds III IV and V. He was responsible for overall investment strategy deal orientation analyses investment and gain realization. Dr. Evnin serves on the board of directors of several privately-held healthcare companies including BioValve Technologies Inc. and Genesoft Inc. He also serves on the board of directors of Medical Portfolio Management L.P. an investment management firm and is chairman of the Scleroderma Research Foundation. Dr. Evnin holds a Ph.D. in biochemistry from the University of California at San Francisco and an A.B. in Molecular Biology from Princeton University. | 